With our unique and established capabilities and strategy for growth, we offer a clear proposition to investors.

Preliminary Results 2022

Key Highlights from Said Darwazah, Executive Chairman and Chief Executive Officer

Key highlights from Khalid Nabilsi, Chief Financial Officer

Key highlights from Riad Mishlawi, President, Injectables

Key highlights from Mazen Darwazah, Executive Vice Chairman and President MENA

Key highlights from Brian Hoffmann, President Generics

Four reasons to invest in Hikma

We have a strong business model with significant opportunities to further enhance our portfolio to drive growth and deliver value for shareholders.


Understanding Hikma

Find out how our business model, strategy and established capabilities support our clear investment proposition

Annual Report 2022

Find out how we are performing in our Annual Report

Download our Corporate Factsheet

Corporate governance

Information on the high standards of governance we’re committed to, our governance structure, Board, key committees, and remuneration policy.

Investor Relations